Target intelligence / Profile preview

Cytochrome P450 6B3 variant 3 (CYP6B3v3)

Target
CYP6B3v3
Molecular classification
Enzyme, Cytochrome P450, Monooxygenase, Heme-thiolate protein
01

Overview

Cytochrome P450 6B3 variant 3 (CYP6B3v3) is a specialized enzyme found in the black swallowtail butterfly, Papilio polyxenes, where it plays a critical role in the detoxification of plant-derived toxins (Hung et al., 1995). Specifically, it metabolizes furanocoumarins, which are defensive chemicals produced by plants in the Apiaceae and Rutaceae families that can cause DNA damage upon UV activation (Wen et al., 2006). CYP6B3v3 is a monooxygenase that converts these hydrophobic toxins into more water-soluble metabolites, allowing the insect to feed on otherwise toxic host plants (Li et al., 2003). While closely related to CYP6B1, CYP6B3v3 has a broader substrate specificity, enabling the metabolism of both linear and angular furanocoumarins, albeit with lower efficiency (Wen et al., 2006). The expression of this enzyme is highly inducible by the presence of furanocoumarins in the larval diet, representing a key evolutionary adaptation to chemical warfare between plants and herbivores (Hung et al., 1995). In agricultural and toxicological research, CYP6B3v3 serves as a model for understanding metabolic resistance and is a potential target for synergists designed to inhibit detoxification enzymes in pests (Scott et al., 1998).

Other names
CYP6B3Cytochrome P450 6B3P450 6B3Papilio polyxenes CYP6B3CYP6B3v3
02

Mechanism of action

Catalyzes the NADPH-dependent monooxygenation of furanocoumarins to facilitate their metabolic detoxification and excretion.

03

Biological functions

Detoxification of plant allelochemicalsMetabolism of xenobioticsAdaptation to host plantsMonooxygenation of furanocoumarins
04

Disease associations

Other
05

Safety considerations

Potential for off-target inhibition of beneficial insect P450sRapid evolution of metabolic resistance in pest populationsHigh sequence similarity among P450 variants complicating specific targeting
06

Interacting drugs

Methoxsalen (Xanthotoxin)

4 more in the full profile.

07

Biomarkers

CYP6B3 mRNA expression levelsCYP6B3 protein levelsFuranocoumarin metabolite concentrations

Beyond the preview

Go deeper on Cytochrome P450 6B3 variant 3 (CYP6B3v3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome P450 6B3 variant 3 (CYP6B3v3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call